These data point out that both PD1+CD28− and PD1+CD28+ T-cell subsets are detectable in ex-vivo peripheral blood of patients with cancers of different derivations and resemble functional and RNA-Seq analysis results from Ag-specific T-cell clones. This evidence concerns the gene CD28 and cancer.